These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 7965285)

  • 1. Blood pressure variability: clinical implications and effects of antihypertensive treatment.
    Parati G; Ravogli A; Frattola A; Groppelli A; Ulian L; Santucciu C; Mancia G
    J Hypertens Suppl; 1994 Jul; 12(5):S35-40. PubMed ID: 7965285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical relevance blood pressure variability.
    Parati G; Di Rienzo M; Ulian L; Santucciu C; Girard A; Elghozi JL; Mancia G
    J Hypertens Suppl; 1998 Aug; 16(3):S25-33. PubMed ID: 9747907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure variability and organ damage.
    Mancia G; Frattola A; Parati G; Santucciu C; Ulian L
    J Cardiovasc Pharmacol; 1994; 24 Suppl A():S6-11. PubMed ID: 7603077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can good surrogate end-points predict the prognosis of hypertensive patients?
    Mancia G; Lanfranchi A; Turri C; Grassi G
    J Hypertens Suppl; 1998 Oct; 16(5):S3-7. PubMed ID: 9868998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study.
    Hermida RC
    Chronobiol Int; 2007; 24(4):749-75. PubMed ID: 17701685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
    de la Sierra A; Gil-Extremera B; Calvo C; Campo C; García-Puig J; Márquez E; Oliván J; Roca Cusachs A; Sanz de Castro S; Pontes C; Delgadillo J
    J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of ambulatory blood pressure monitoring in elderly hypertensive patients.
    Mancia G; Parati G
    Blood Press Suppl; 2000; 2():12-6. PubMed ID: 11055466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons to be learned from 24-hour ambulatory blood pressure monitoring.
    Mancia G; Omboni S; Parati G
    Kidney Int Suppl; 1996 Jun; 55():S63-8. PubMed ID: 8743513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What are the approaches for evaluating antihypertensive treatment by 24 h ambulatory blood pressure monitoring?
    Neutel JM; Smith DH; Weber MA
    Blood Press Monit; 1999; 4 Suppl 2():S23-8. PubMed ID: 10822419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of ambulatory blood pressure monitoring in evaluating hypertensive patients and their treatment.
    Lacourcière Y
    Can J Cardiol; 1993; 9(1):73-9. PubMed ID: 8439831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hypertension based on measurement of blood pressure variability: lessons from animal studies.
    Su DF
    Curr Opin Cardiol; 2006 Sep; 21(5):486-91. PubMed ID: 16900013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDA guidelines on trough: peak ratios in the evaluation of antihypertensive agents. United States Food and Drug Administration.
    Meredith PA; Elliott HL
    J Cardiovasc Pharmacol; 1994; 23 Suppl 5():S26-30. PubMed ID: 7609502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of ambulatory blood pressure.
    Imai Y
    Blood Press Monit; 1999 Oct; 4(5):249-56. PubMed ID: 10547646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value of blood pressure variability.
    Parati G; Ulian L; Santucciu C; Tortorici E; Villani A; Di Rienzo M; Mancia G
    Blood Press Suppl; 1997; 2():91-6. PubMed ID: 9495635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure reduction and end-organ damage in hypertension.
    Mancia G; Frattola A; Groppelli A; Omboni S; Parati G; Ulian L; Villani A
    J Hypertens Suppl; 1994 Nov; 12(8):S35-41; discussion S41-2. PubMed ID: 7707154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.